17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression.

@article{Malek200617BetaestradiolIT,
  title={17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression.},
  author={Daniela Malek and Ronald Gust and Burkhard Kleuser},
  journal={European journal of pharmacology},
  year={2006},
  volume={534 1-3},
  pages={39-47}
}
Motility of malignant cells plays a crucial role for the metastasis of tumours. Both, 17-beta-estradiol and transforming growth factor-beta (TGF-beta), induce migration of MCF-7 breast cancer cells and simultaneous treatment resulted in an additive effect of the migratory response. But most interestingly, when cells were preincubated with 17-beta-estradiol, the ability of TGF-beta to evoke chemotaxis was drastically diminished. Abrogation of Smad signalling indicated that this pathway is… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer

Journal of Mammary Gland Biology and Neoplasia • 2011
View 5 Excerpts
Highly Influenced

Metastatic phenotype is regulated by estrogen in thyroid cells.

Thyroid : official journal of the American Thyroid Association • 2010

Similar Papers

Loading similar papers…